Method for producing methyl- {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-p yrazolo[3,4-b]pyridino-3-yl]pyrimidino-5yl}methyl carbamate and its purification for use thereof as pharmaceutical substance

Details for Australian Patent Application No. 2010323227 (hide)

Owner Bayer Pharma Aktiengesellschaft

Inventors Mais, Franz-Josef; Rehse, Joachim; Joentgen, Winfried; Siegel, Konrad

Agent Davies Collison Cave

Pub. Number AU-A-2010323227

PCT Pub. Number WO2011/064171

Priority 09177371.3 27.11.09 EP

Filing date 22 November 2010

Wipo publication date 3 June 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

14 June 2012 PCT application entered the National Phase

  PCT publication WO2011/064171 Priority application(s): WO2011/064171

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010323229-Method and apparatus for helical cutting of a tubular film

2010323220-Nebulizer